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1. Introduction
In eukaryotic cells, the nucleus is segregated from the 
cytoplasm by a double-layer membrane termed nuclear 
envelope. The outer nuclear membrane is contiguous with the 
endoplasmic reticulum, while the inner nuclear membrane is 
associated with a fi lamentous network of proteins called 
the nuclear lamina (Fawcett 1966). The nuclear pore 
complexes, which mediate import and export of molecules, 
are embedded in the nuclear envelope at regular intervals. 
Major components of the lamina are a group of nuclear 
proteins termed lamins which belong to the intermediate 
fi lament superfamily of proteins (reviewed by Goldman et al 
2002; Gruenbaum et al 2005). Lamins have been shown to 
be involved in a number of nuclear processes, and increasing 
evidence suggests that lamins can interact directly with 
proteins that function in diverse cellular pathways.
In studies carried out by several groups in the past
decade, >150 mutations in the human lamin A gene
(LMNA) have been linked to at least 10 highly degenerative, 
heritable, rare disorders that primarily affect muscle, 
adipose, bone or neuronal tissues and also result in 
premature ageing syndromes. These disorders have been 
collectively termed laminopathies. The human lamin A
gene has been mapped to chromosome 1q21.2 – 1q21.3 
(Wydner et al 1996); mutations observed in laminopathies 
have been linked to LMNA using both positional cloning and 
candidate gene approaches. It is indeed rare to fi nd different 
mutations in the same gene giving rise to distinct, possibly 
unrelated diseases. Though we are far from understanding 
how lamin mutations result in disease, phenotypes of 
the various diseases have given valuable clues about the 
functional roles of lamins, especially in tissue-specifi c 
differentiation.
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In this review, we will briefl y summarize the structure 
and functions of lamins, and then discuss the laminopathies 
with reference to the actual disease conditions in humans 
and studies in model organisms as well as in cell culture, 
and fi nally describe possible mechanisms of pathogenesis. 
Further details of clinical fi ndings can be found in the 
original references and have been recently reviewed by 
Jacob and Garg (2006).
2. Lamin structure and functions
2.1 Structural organization
Lamins typically form a stable polymer situated beneath the 
inner nuclear membrane, but have also been located in the 
interior of the nucleus, as shown in fi gure 1 (Goldman et al 
1992; Hozak et al 1995; Jagatheesan et al 1999). The lamina 
plays an essential role in maintaining the integrity of the 
nuclear envelope and provides anchoring sites for chromatin, 
and is hence considered to be an important determinant of 
interphase nuclear architecture (reviewed in Stuurman et al 
1998; Goldman et al 2002; Shumaker et al 2003; Gruenbaum 
et al 2005). Two major kinds of lamins are present in 
vertebrate cells: B-type lamins (B1 and B2) that are found in 
nearly all somatic cells, and A-type lamins (A and C) which 
have been detected primarily in differentiated cells. The 
lamin genes are highly conserved across species. Lamins 
A and C (henceforth called lamin A/C) are alternatively 
spliced products of the lamin A gene, LMNA, whereas lamins 
B1 and B2 are coded by two separate genes, LMNB1 and 
LMNB2. Additional splice variants are germ cell-specifi c 
lamins C2 and B3 which are encoded by LMNA and LMNB2 
respectively, and a minor somatic cell isoform termed lamin 
A∆10. Drosophila melanogaster has two lamin genes, lamin 
Dm0, which is expressed in most cells and lamin C, whose 
expression is developmentally regulated. Caenorhabditis 
elegans has only one lamin gene, lmn-1, which is expressed 
Figure 1. Schematic representation of nuclear envelope. The major components of the nuclear envelope and some of the nuclear 
proteins that interact with the lamins are shown here. The A-type lamins are concentrated at the periphery (thick lines) and also distributed 
throughout the nucleoplasm (thin lines). ONM, outer nuclear membrane; INM, inner nuclear membrane; NPC, nuclear pore complex; LAP, 
lamina-associated polypeptide; LBR, lamin B receptor; HP1, heterochromatin protein 1; pRb, retinoblastoma protein; BAF, barrier-to-
autointegration factor; SFC, splicing factor compartment.
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in all cells except for mature sperm. Genome sequence 
analysis of yeast and Arabidopsis indicates that these species 
do not have lamins and, though functional homologs are 
likely to exist, these have not yet been defi nitively identifi ed. 
Thus lamins appear to have evolved in animal cells.
Lamins belong to the intermediate fi lament family of 
proteins and contain a characteristic central α-helical rod 
domain, fl anked by relatively fl exible N-terminal and C-
terminal segments. The C-terminii of lamins A, B1 and B2 
bear a CaaX motif (C is cysteine, a is an aliphatic amino 
acid and X is any amino acid) which is post-translationally 
modifi ed by farnesylation, and, in the case of lamin A, is 
subjected to a further maturation step by which pre-lamin 
A is proteolytically cleaved to give mature lamin A. In vitro 
studies have shown that all three domains of the protein 
are essential for lamin assembly and functions. The rod 
domains of two lamin monomers associate to form a two-
stranded coiled-coil α-helix, which is the basic dimeric 
subunit involved in formation of the higher order structure 
of the lamin fi lament. Head-to-tail interactions of lamin 
dimers lead to formation of 2–3 nm diameter protofi laments 
which have the propensity to associate laterally in different 
confi gurations such as parallel, staggered or half-staggered 
to give rise to the 10 nm lamin fi lament (Stuurman et al 
1998). Although formation of the 10 nm fi lament has not 
been observed in vitro with vertebrate lamins, the assembly 
of the ~10 nm fi laments has been observed with C. elegans 
lamin (Karabinos et al 2003). It has been suggested that 
higher-order lamin assembly might also involve interactions 
with other molecules in vivo. 
2.2 Assembly and disassembly of lamins
During mitosis, phosphorylation of essential serine residues 
on either end of the rod domain of lamin by p34/cdc2 kinase 
results in depolymerisation of the lamina into dimers and 
tetramers. The lamina is reassembled towards late telophase 
and in early G1 phase of the cell cycle; lamin B appears 
to be incorporated when the nuclear membranes and pores 
are assembling in the nascent nuclear envelope, whereas 
lamin A/C is imported through the nuclear pores towards 
the end of cytokinesis (reviewed in Gant and Wilson 1997). 
An important fi nding reported recently is that lamin B is 
essential for formation of a matrix-like network required for 
assembly of the mitotic spindle (Tsai et al 2006). In addition 
to the typical nuclear rim pattern, lamin A and B tagged with 
green fl uorescent protein (GFP) have been observed to form 
a veil of fl uorescence in the nucleoplasm of interphase cells 
(Broers et al 1999; Moir et al 2000b). During apoptosis, 
lamins are cleaved by caspases, and this helps to disassemble 
the lamina and allows the nuclear events of apoptosis such 
as reduction in nuclear size and chromatin condensation to 
proceed (Cohen et al 2001).
2.3 Lamin-binding proteins
Majority of the proteins associated with the inner nuclear 
membrane interact with lamins and/or chromatin. Prominent 
lamin-binding proteins are emerin, lamin B receptor, and 
lamin-associated-polypeptides (LAPs) 1 and 2. Emerin, 
LAP2 and another envelope protein MAN1 possess a 
40-residue folded motif called the LEM domain (derived 
from LAP, emerin, MAN1) that binds directly to barrier-
to-autointegration factor (BAF), a conserved DNA binding 
protein that is involved in higher-order chromatin structure 
and is important for nuclear assembly (reviewed in Zastrow et 
al 2004). LAP2α is an important binding partner for lamin A 
in the interior of the nucleus (Dechat et al 2000; Markiewicz 
et al 2002). These fi ndings suggest that interactions between 
lamins and its binding partners might infl uence chromatin 
structure and gene activity. Moreover, many of the mutations 
that cause laminopathies also result in reduced amounts of 
emerin at the nuclear envelope (Östlund et al 2001; Raharjo 
et al 2001; Vigouroux et al 2001).
A newly described class of proteins termed nesprins 
(also called Syne/ANC-1 proteins) span the outer nuclear 
membrane, and smaller nesprin isoforms localized in the 
inner nuclear membrane are able to bind to lamin A as 
well as emerin. The nesprins are large proteins with several 
spectrin repeats, and exist in many forms with tissue-specifi c 
expression patterns due to alternate splicing (Mislow et al 
2002; Zhang et al 2002). Some of the nesprins contain a 
calponin homology domain which is known to bind to actin; 
nesprins have also been localized in multiple cytoplasmic 
compartments and in association with the actin cytoskeleton 
(Zhang et al 2005). Genetic studies suggest that the 
nesprins are required for the anchorage of the nucleus to the 
cytoskeleton (Starr and Han 2003), and may thus be involved 
in correct nuclear positioning as well as transmission of 
regulatory signals from the cell surface to the nucleus. A 
new class of inner nuclear membrane proteins called the 
SUNs are likely to provide a link between the cytoplasm 
and nuclear interior as they can bind to nesprins at the outer 
nuclear membrane (Padmakumar et al 2005). A recent study 
has reported binding of the lamins to nuclear titin, a protein 
essential for mitotic chromosome condensation, suggesting a 
possible role for titin in nuclear organization as well (Zastrow 
et al 2006). Loss-of-function mutations in Drosophila lamin 
Dm0 suggest that lamins might be involved in additional 
functions such as cytoplasmic organisation and cell polarity 
(Guillemin et al 2001).
2.4 Lamins and DNA replication
Several studies indicate that a normal lamina organization 
is required for DNA replication (Newport et al 1990; Meier 
et al 1991). Although it is possible to replicate DNA in vitro 
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with purifi ed factors in the absence of lamins (Walter et 
al 1998), an intact lamina is essential for DNA replication 
in assembled nuclei and cells. When N-terminal deletion 
mutants of human lamin A (Spann et al 1997; Moir et al 
2000a) or Xenopus lamin B1 (Ellis et al 1997) were added 
to assembled nuclei, they disrupted lamin organization and 
inhibited DNA synthesis. A direct role for lamins in the 
spatial organization of DNA replication has been suggested 
by evidence of colocalization of lamin B with replication 
foci and replication factors such as PCNA in NIH 3T3 
cells (Moir et al 1994), and colocalization of lamin A with 
replication factors at specifi c stages of S phase in primary 
mammalian cells (Kennedy et al 2000).
2.5 Lamins and gene regulation 
Early studies on the developmental and tissue-specifi c 
expression of A-type lamins in mouse and Drosophila 
pointed to a possible involvement of lamins in gene 
regulation (Röber et al 1989; Riemer et al 1995). A-
type lamins have been shown to associate with specifi c 
transcription factors such as the retinoblastoma protein 
(pRb) (Mancini et al 1994; Ozaki et al 1994), sterol response 
element binding protein 1 (SREBP1) (Lloyd et al 2002), a 
Kruppel-like protein, MOK2 (Dreiullet et al 2002) and more 
recently, c-Fos (Ivorra et al 2006). Lamin A/C can bind to 
protein phosphatase 2A to modulate TGF-β1 signalling in 
fi broblasts (van Berlo et al 2005). There is evidence that 
localization of specifi c genes at the nuclear periphery may 
lead to transcriptional silencing. In Drosophila, insertion 
of the gypsy insulator into a gene sequence causes its 
translocation to the nuclear envelope (Gerasimova and 
Corces 1998). Association of the POU domain repressor 
protein Oct-1 with lamin B1 has been correlated with its 
repressor activity (Imai et al 1997). Lamin B together with 
LAP2β forms functional complexes with the transcription 
factors germ-cell-less (GCL) and DP to repress E2F (de 
la Luna et al 1999; Nili et al 2001). Lamins can also bind 
directly to histones (Taniura et al 1995).
Defi nitive evidence of a role for lamins in organization 
of transcription has been provided by the following studies. 
Goldman and colleagues have shown that expression of an 
N-terminal deletion mutant of lamin A, ∆NLA, in cells leads 
to disruption of the lamina and inhibition of RNA polymerase 
II (pol II) transcription, without affecting pol I or pol III 
transcription (Spann et al 2002). Our group has shown that 
nucleoplasmic lamins termed lamin speckles are relocalized 
into enlarged domains upon treatment with transcriptional 
inhibitors, and that disruption of these domains in various 
mammalian cells disrupts splicing factor compartments and 
inhibits RNA pol II transcription (Kumaran et al 2002). We 
have shown that lamin speckles colocalize with splicing 
factor compartments using a monoclonal antibody LA-2H10 
that specifi cally recognizes A-type lamins (Jagatheesan 
et al 1999). The epitope sequence for this antibody has 
been determined to be NIYSEEL, which corresponds to 
residues 209-215 in lamin A/C and is present exclusively 
in A-type lamins (Bh Muralikrishna and S Thanumalayan, 
unpublished data). This peptide blocks antibody reactivity 
in immunofl uorescence assays whereas sequences with 
lower homology in lamins B1 or B2 have no effect. 
Furthermore, RNAi to lamin A/C disrupts lamin speckles 
in addition to the peripheral lamina, and also disrupts 
splicing factor compartments, suggesting an important role 
for lamin speckles in the maintenance of splicing factor 
compartments (B V Gurudatta, unpublished data). Splicing 
factor compartments are dynamic domains involved in the 
storage and recruitment of splicing factors (Spector 2003). 
Previous studies have indicated presence of the lamins in 
purifi ed preparations of splicing factor compartments (Mintz 
et al 1999). 
3. Laminopathies
3.1 Muscular dystrophies
The clinical condition termed Emery-Dreifuss muscular 
dystrophy (EDMD) was fi rst described by Alan Emery and 
Fritz Dreifuss in the 1960’s (Emery and Dreifuss 1966). This 
is marked by contractures of the elbows, achilles tendons 
and posterior neck, slow progressive muscle wasting and 
cardiomyopathy with atrioventricular conduction block. The 
gene responsible for X-linked EDMD was identifi ed by a 
positional cloning approach and named ‘emerin’ (Bione et al 
1994). Emerin is an inner nuclear membrane protein which 
has been shown to interact with A-type lamins and, together 
with another protein, BAF, mediates lamin-chromatin 
interactions (Zastrow et al 2004). Emerin was shown to be 
defi cient in cells of patients suffering from EDMD (Manilal 
et al 1996; Nagano et al 1996). Subsequently an autosomal 
dominant form of EDMD has been attributed to mutations 
in LMNA (Bonne et al 1999; Brown et al 2001). Most of 
the mutations are missense mutations and a few are small 
deletions; mutations are found in all the exons of the gene 
except exon 12. Both familial and sporadic mutations have 
been identifi ed. For the same mutation, there is considerable 
variability in the range of symptoms observed in different 
families as well as within a family; some patients show the 
full clinical symptoms of EDMD whereas others show only 
cardiac symptoms (Bonne et al 2000). Hence the occurrence 
of modifi er genes cannot be ruled out. A rare autosomal 
recessive form of EDMD is caused by the inheritance of 
two different mutant LMNA alleles (Raffaeli Di Barletta 
et al 2000). A case of autosomal recessive EDMD has 
been documented to be due to homozygosity for a H222Y 
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mutation (Sanna et al 2003); the parents of the individual 
did not show skeletal or cardiac dysfunction. In addition, 
missense mutations and splicing defects in LMNA have 
been linked to autosomal dominant limb girdle muscular 
dystrophy type 1B (LGMD1B) (Muchir et al 2000). 
LGMD1B is a slowly progressing disease characterized 
by weakness and wasting of shoulder and pelvic muscles 
due to necrosis, and is accompanied by cardiac conduction 
defects in several patients. A lethal phenotype for a newborn 
child from an LGMD1B family has been attributed to 
homozygosity for a Y259X nonsense mutation (Muchir et al 
2003; van Engelen et al 2005).
3.2 Dilated cardiomyopathy
Dilated cardiomyopathy (DCM) may be genetic in origin 
or brought about by a variety of factors such as viruses, 
alcohol, toxic chemicals etc. The familial cases of DCM are 
due to mutations in a number of different genes. Autosomal 
dominant DCM type 1A is associated with mutations in 
LMNA (Fatkin et al 1999). DCM is a progressive disease 
and is characterized by ventricular dilation and systolic 
dysfunction. DCM is usually accompanied by conduction 
defects, as well as skeletal muscle involvement in patients 
with LMNA mutations. Due to the risk of sudden death 
among such patients, an effective therapeutic intervention 
is the use of an implantable cardioverter-defi brillator to treat 
possibly lethal tachyarrhythmias (Meune et al 2006).
3.3 Lipodystrophies
Dunnigan-type familial partial lipodystrophy (FPLD) is an 
autosomal dominant disorder characterized by loss of fat 
tissue from the extremities and excess fat accumulation 
on the face and neck, beginning at puberty. This is 
accompanied by insulin-resistant diabetes, hyperlipidemia, 
and atherosclerotic vascular disease. The gene responsible 
for FPLD has been identifi ed as LMNA by several groups 
(Cao and Hegele 2000; Shackleton et al 2000; Speckman et 
al 2000). Approximately 90% of the mutations are localized 
to exon 8, with substitutions at arginine at 482 position 
being found in 75% of cases. Cardiomyopathy and possible 
symptoms of LGMD have been reported in FPLD patients 
with mutations in exon 1 (Garg et al 2002; van der Kooi et 
al 2002) but not in FPLD patients with mutations in exons 
8 or 11.
Generalized lipodystrophy has been associated with 
LMNA mutations (Caux et al 2003) and is accompanied 
by insulin-resistant diabetes and cardiomyopathy. A patient 
with Seip syndrome and showing generalized lipodystrophy 
together with features of progeroid syndromes including 
short stature, scleroderma-like skin, and early graying of 
hair has been reported to harbour a T10I LMNA mutation 
(Csoka et al 2004a).
3.4 Progeria syndromes
The most dramatic effects of mutations in LMNA have been 
observed in the premature ageing disorder Hutchinson-
Gilford progeria syndrome (HGPS), and were reported 
by two groups in 2003 (De Sandre-Giovannoli et al 2003; 
Eriksson et al 2003). HGPS is a very rare disorder (about 
one in a million) that leads to early mortality, usually in 
the second decade of life. HGPS is an autosomal-dominant 
condition that is characterized by short stature, early thinning 
of skin, loss of subcutaneous fat, premature atherosclerosis 
and cardiac failure leading to death. Majority of the cases are 
due to a de novo missense mutation (GGC to GGT) in exon 
11 that does not cause an amino acid change (G608G), but 
leads to creation of an abnormal splice donor site that results 
in expression of a truncated pre-lamin A protein (also termed 
progerin) with loss of 50 amino acids from the C-terminus, 
but retention of the C-terminal CaaX motif. Other missense 
mutations such as R471C and R527C have also been 
described which do not result in expression of truncated pre-
lamin A protein (Cao and Hegele 2003). LMNA mutations 
that lead to atypical progeroid syndromes have been reported 
(Csoka et al 2004a). Chen et al (2003) have described cases 
with atypical Werner’s syndrome with an early adult onset 
phenotype and less severe disease severity than HGPS. The 
patients were found to have missense mutations in LMNA. 
Recently, a case of autosomal recessive HGPS has been 
reported with a K542N mutation in LMNA (Plasilova et al 
2004); phenotypes in the family of this patient overlapped 
with those observed in mandibuloacral dysplasia (described 
below).
3.5 Neuropathy
An autosomal recessive mutation at R298C of LMNA gives 
rise to an axonal neuropathy termed Charcot-Marie-Tooth 
disorder (CMT) type 2B (De Sandre-Giovannoli et al 2002). 
Patients showed sensory impairment with some reduction in 
motor nerve conduction velocity. The heterozygous carriers 
did not exhibit clinical signs of neuropathy. Recently, cases 
have been reported with the dominant LMNA mutations 
E33D and R571C, which result in overlapping symptoms of 
muscular dystrophy and neuropathy, and with cardiac disease 
(Goizet et al 2004; Benedetti et al 2005; Vital et al 2005). 
3.6 Bone and skin disorders
Mandibuloacral dysplasia (MAD) is a rare, autosomal 
recessive disorder characterized by postnatal growth 
retardation, skull and facial anomalies, skeletal abnormalities, 
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mottled skin pigmentation, partial lipodystrophy and signs of 
premature ageing (Novelli et al 2002). Several patients have 
been reported to have the R527H homozygous mutation 
in LMNA. A patient with a R527C/R471C heterozygous 
mutation, reported to have atypical progeria, also showed 
symptoms of MAD (Cao and Hegele 2003). In addition, 
MAD is caused by mutations in Zmpste24 protease which 
is involved in the processing of pre-lamin A to lamin A 
(Agarwal et al 2003). Metabolic studies have revealed 
hyperinsulinemia in many subjects of MAD.
Mutations in LMNA as well as Zmpste24 are associated 
with restrictive dermopathy, a rare disorder characterized 
by intra-uterine growth retardation, tight and rigid skin with 
erosions, facial malformation, bone mineralization defects 
and early neonatal mortality (Navarro et al 2004, 2005; 
Shackleton et al 2005). Some of the mutations in LMNA or 
Zmpste24 led to creation of premature termination codons, 
resulting in truncated proteins. One case has been diagnosed 
with the G608G mutation identical to that observed in HGPS 
(Navarro et al 2004), with phenotypes in between those of 
HGPS and restrictive dermopathy. Thus HGPS, MAD 
and restrictive dermopathy appear to represent a clinical 
spectrum of related disorders, with the severity depending 
on the dysfunction of lamin A/C. Recently a case has been 
reported with a combination of myopathy and progeria, 
bearing the S143F mutation (Kirschner et al 2005). 
At this juncture, the role of other factors or modifying 
genes in laminopathies cannot be ruled out. It is also possible 
that more genetic disorders may be attributed to mutations in 
LMNA or related genes in future studies. Mutations in the 
inner nuclear membrane protein, lamin B receptor, which 
interacts with lamins and chromatin, lead to an autosomal 
dominant genetic condition termed Pelger-Huët anomaly 
(Hoffman et al 2002), which is characterized at the cellular 
level by blood granulocytes displaying abnormal nuclei 
and chromatin, and is associated with varying levels of 
developmental delay, epilepsy and skeletal abnormalities. 
A recessive disorder called Greenberg skeletal dysplasia is 
a lethal chondrodystrophy which has also been attributed to 
the lamin B receptor gene (Waterham et al 2003). Mutations 
in MAN1 cause inherited diseases that mainly affect bone 
and skin tissues (Hellemans et al 2004). A mutation in the 
LAP2α gene has been linked to DCM (Taylor et al 2005). At 
present, no mutations in the lamin B genes have been linked 
to human disease, suggesting that loss of one of the B-type 
genes is either without consequence or results in death in 
early development, as observed in a mouse knock-out of the 
lamin B1 gene (Vergnes et al 2004). 
4. Animal models for laminopathies
Valuable insights into the functions of LMNA have been 
obtained by gene targeting studies in mice. A lamin A/C 
gene knock-out in exons 8–11 leads to the development 
of muscular dystrophy symptoms resembling EDMD and 
results in mortality by 2 months of age (Sullivan et al 1999). 
The Lmna−/− animals also show loss of white adipose tissue 
(but not partial lipodystrophy or insulin resistance), cardiac 
dysfunction (Nikolova et al 2004), non-myelinated axons 
and reduced axon density (De Sandre-Giovannoli et al 
2002). Heterozygous Lmna−/− mice, however, do not show 
any symptoms that could arise due to haploinsuffi ciency. 
This is unlike the case of the human EDMD Q6X mutation, 
which results in a stop codon at position 6 and effectively 
encodes only one copy of intact lamin A (Bonne et al 1999). 
A mouse model for progeria has been reported for the 
L530P mutation by a gene knock-in technique (Mounkes 
et al 2003). Although this mutation is associated with 
EDMD in humans, the aberrantly spliced forms of lamin 
A observed in this mouse model might have given rise to 
the progeria-like symptoms. A mouse model for EDMD has 
been obtained by gene targeting of a mouse Lmna fragment 
with a H222P mutation by a knock-in approach (Arimura 
et al 2005). This mutation had been earlier identifi ed in a 
family with autosomal dominant EDMD (Bonne et al 2000). 
Homozygous knock-in mice developed skeletal muscle 
degeneration and cardiac dysfunction by adulthood but did 
not show symptoms at earlier stages. Another mouse model 
with knock-in of the N195K mutation, which leads to DCM 
in humans, shows features characteristic of this disease. At 
the cellular level, organization of the cardiomyocytes was 
disrupted, together with misregulation of factors required 
for normal cardiac development (Mounkes et al 2005). 
Another useful mouse model is the Zmpste24-null mouse 
which develops DCM and muscular dystrophy, as well 
as progeria-like features (Bergo et al 2002; Pendás et al 
2002). Unprocessed pre-lamin accumulates in the nuclei 
of these mice, leading to irregular nuclei with herniations 
and nuclear blebs. A progerin knock-in model has been 
reported wherein heterozygous mice exhibit growth 
retardation and fi broblasts from these mice show aberrant 
nuclear morphology (Yang et al 2005). In a recent report, 
a mouse transgenic model bearing the human LMNA gene 
with a G608G mutation shows a progressive loss in vascular 
smooth muscle cells (Varga et al 2006), as seen in HGPS 
patients (McClintock et al 2006). It may be noted that most 
of these mouse models show disease symptoms only in the 
homozygous state, unlike the autosomal dominant nature of 
the human diseases, where only one allele is mutated. Thus 
all features of the human diseases might not be faithfully 
reproduced by the mouse models.
In C. elegans, which has a single lamin gene, loss of lamin 
causes abnormal heterochromatin organization, unequal 
separation of chromosomes and abnormal distribution of 
nuclear pore complexes, leading to embryonic lethality 
(Liu et al 2000). Mutations in Drosophila lamin Dm0
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(a B-type lamin) display developmental abnormalities 
in organogenesis, locomotion, tracheal development and 
nuclear positioning in the oocyte and eye, as well as aberrant 
nuclear morphology (Lenz-Bohme et al 1997; Guillemin
et al 2001; Patterson et al 2004; Osouda et al 2005). In 
a recent study, mutations in Drosophila lamin C, an A-
type lamin, have been shown to be lethal at the pre-pupal 
stage, and an R401K mutation (homologous to the R386K 
mutation that causes EDMD in humans) showed defects 
in nuclear morphology (Schulze et al 2005). A detailed 
study carried out by us indicates that Drosophila lamin C 
is essential for tissue-specifi c development and chromatin 
organization (B V Gurudatta, L S Shashidhara and Veena K 
Parnaik, manuscript in preparation).
5. Mechanisms of pathogenesis
There is currently considerable interest in understanding 
how mutations in LMNA lead to a broad spectrum of 
diseases. The major question is how do mutations in lamin 
A, which is expressed in nearly all differentiated tissue 
types, cause several diseases, some of which are tissue-
specifi c. Two hypotheses have been proposed to explain the 
clinical observations. The “mechanical stress” hypothesis 
states that abnormalities in nuclear structure, resulting from 
mutations in lamin A, weaken the nuclear lamina-envelope 
network and thus lead to increased susceptibility to cellular 
damage by physical stress (Sullivan et al 1999). The “gene 
expression” hypothesis proposes that nuclear lamin plays a 
role in tissue-specifi c gene expression which can be altered 
by mutations in lamin A (Wilson 2000). A number of studies 
have been carried out with cells from patients and mouse 
models, as well as exogenously expressed mutants, to address 
this problem (reviewed by Hutchison and Worman 2004; 
Worman and Courvalin 2004; Smith et al 2005; Mattout et al 
2006). Broadly speaking, it may be concluded that the above 
hypotheses are not mutually exclusive. Furthermore, effects 
on gene expression can impair downstream events in diverse 
ways, as will be evident from the following discussion.
5.1 Effects on nuclear integrity
Abnormal nuclear morphology has been observed in cells 
from patients with various laminopathies. Fibroblasts 
from patients with EDMD, LGMD, CMD and FPLD show 
abnormal nuclear phenotypes with nuclear blebbing and 
aberrant lamin foci in up to 20% of cells (Vigouroux et al 
2001; Capanni et al 2003; Favreau et al 2003; Muchir et 
al 2004). Severe nuclear abnormalities have been reported 
in HGPS cells, including lobulation, blebbing and loss of 
heterochromatin (Eriksson et al 2003; De Sandre-Giovannoli 
et al 2003; Goldman et al 2004). It has been proposed that 
the accumulation of pre-lamin A leads to pathogenesis, and 
this is supported by evidence for improvement of nuclear 
morphology by inhibiting abnormal splicing (Scaffi di and 
Misteli 2005), blocking farnesyl transferase activity in cells 
(Capell et al 2005; Columbaro et al 2005; Glynn and Glover 
2005; Mallampalli et al 2005; Yang et al 2005; Varga et al 
2006), knocking out the Zmpste24 gene in a mouse model 
(Fong et al 2006a), or reducing the levels of progerin by 
RNA interference assays (Huang et al 2005). Importantly, 
a recent report indicates that a farnesyl transferase inhibitor 
administered to Zmpste24 defi cient mice can decrease 
progeria-like disease symptoms and improve survival (Fong 
et al 2006a), raising possibility of the benefi cial effects of 
these drugs in humans. It has been recently reported that 
nuclei from old individuals acquire defects that are similar 
to those seen in cells from HGPS patients, and this has been 
attributed to accumulation of progerin (Scaffi di and Misteli 
2006). A study with C. elegans has shown that there are age-
dependent changes in nuclear shape and loss of peripheral 
heterochromatin in non-neuronal cells, supporting the 
hypothesis that defects in nuclear architecture might be 
a cause for normal ageing. The rate of these changes is 
affected by the insulin/IGF-1-like signalling pathway, which 
plays an important role in the ageing process (Haithcock
et al 2005). 
The Lmn−/− mouse model has provided an informative 
system to study defects associated with lamin A defi ciency, 
in particular those leading to muscular dystrophy and 
cardiomyopathy. Fibroblasts from Lmn−/− mice have aberrant 
nuclear morphology, show herniations of the envelope and 
mislocalize emerin. In response to mechanical strain, these 
fi broblasts exhibit increased nuclear deformations and 
defective mechanotransduction, together with reduced 
expression of genes activated by NF-κB (Lammerding et al 
2004). Lmn−/− mice also develop DCM, and cardiomyocytes 
from these mice show abnormal nuclear architecture with 
relocalization of heterochromatin to the nuclear interior, 
and, interestingly, changes in localization of the cytoplasmic 
fi lament protein desmin, thus leading to contractile 
dysfunction (Nikolova et al 2004). These two studies 
suggest that mutations in lamin A may cause striated muscle 
disease by impaired nuclear mechanics and secondary 
changes in gene expression, thus supporting the mechanical 
stress hypothesis for lamin pathogenesis. A further report 
on loss of mechanical stiffness in Lmn−/− fi broblasts is 
consistent with this hypothesis, and also suggests that a loss 
of physical interactions between lamins and the cytoskeleton 
may lead to general cellular weakness (Broers et al 2004). 
Interestingly, a recent report indicates that mice which have 
been targeted to express only lamin C and not lamin A are 
healthy and exhibit only minimal nuclear abnormalities 
(Fong et al 2006b). Hence lamin A and pre-lamin A appear 
to be dispensable in the mouse.
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Exogenous expression of several lamin A/C mutants in 
mouse or human cells causes aberrant nuclear morphology, 
altered lamina assembly, mislocalization of emerin and 
disruption of the endogenous nuclear lamina (Östlund 
et al 2001; Raharjo et al 2001; Vigouroux et al 2001; 
Bechert et al 2003; Favreau et al 2003). Aberrant nuclear 
morphology results in cellular senescence, downregulation 
of transcription and apoptosis. Most of the mutants in the rod 
domain which cause EDMD affect lamin assembly and show 
increased mobility in live cells (Gilchrist et al 2005; Broers 
et al 2005). Some of the mutations in the C-terminal domain 
affect binding to emerin though the mutant proteins correctly 
assemble into the nuclear rim. The R482W mutation which 
causes FPLD does not affect fi lament stability (Gilchrist
et al 2004), and this is consistent with predictions from
the crystal structure of the C-terminal globular domain 
(Dhe-Paganon et al 2002). 
5.2 Effects on muscle differentiation
Since the majority of mutations in LMNA affect muscle 
tissue, there is considerable interest in understanding the role 
played by A-type lamins in muscle development and effects 
of mutations on this process. Based on the mechanical stress 
hypothesis mentioned above, it is possible that muscle cells 
under high mechanical stress are unable to survive due to loss 
in nuclear integrity, leading to loss in cells and a dystrophic 
phenotype. The second possibility is that lamin A/C plays 
a specifi c role in muscle differentiation and mutations in 
lamin A/C may affect the muscle differentiation programme, 
leading to aberrant or incomplete differentiation due to 
misregulation of muscle-specifi c gene expression, which 
eventually leads to a dystrophic syndrome.
Favreau and coworkers have analysed the differentiation 
capacity of a stable clone of C2C12 myoblasts expressing a 
common EDMD-causing lamin A mutation at arginine 453, 
R453W (Favreau et al 2004). These cells were defi cient in 
expression of myogenic markers like myogenin, did not 
exit the cell cycle properly and were eventually targeted 
for apoptosis. Further, these cells showed persistence 
of the hyperphosphorylated form of pRb, though pRb is 
hypophosphorylated during normal myogenesis. Also, the 
muscle regulator Myf5 was expressed at high levels unlike 
in normal cells. Cells expressing the R482W FPLD mutation 
were able to differentiate normally. Subsequent studies 
have shown that the EDMD mutation W520S also inhibits 
myogenin expression and blocks myoblast differentiation 
(Markiewicz et al 2005). 
The authors have investigated the effects of a range of 
EDMD missense mutants on C2C12 myoblast differentiation 
(unpublished results). The mutations studied were G232E, 
Q294P and R386K which cause autosomal dominant 
EDMD (Bonne et al 2000) and R482L that is prevalent in 
FPLD patients (Shackleton et al 2000). These mutants were 
expressed as GFP-fusion proteins in C2C12 myoblasts, 
under conditions wherein levels of ectopically expressed 
proteins were 20-30% of endogenous lamin A. As seen 
from table 1, G232E, Q294P and R386K predominantly 
assembled into intranuclear aggregates and often disrupted 
nuclear morphology, whereas R482L and wild-type GFP-
lamin A were typically incorporated into the nuclear rim in 
~90% of transfected cells after 24 h of transient transfection 
(see fi gure 2). As the G232E, Q294P and R386K mutations 
are in the rod domain of the protein (see fi gure 2A), these 
are likely to disrupt fi lament assembly and form aggregates, 
as observed earlier with FLAG-tagged R386K (Östlund et 
al 2001), though low amounts of exogenous protein may be 
incorporated into the peripheral lamina. When transfected 
myoblasts were induced to differentiate to multinucleated 
myotubes by serum depletion, there was extensive loss of 
cells expressing lamin aggregates, whereas cells displaying 
Table 1 Properties of C2C12 myoblasts expressing GFP-lamin A.
Mutation
          Nuclear localization (%)a    Cell survival in DM (%)b
Rim Aggregates Rim Aggregates
G232E 13.84 86.14 23.70 2.13
Q294P 8.46 91.54 23.19 1.86
R386K 16.45 83.55 15.52 1.04
R482L 88.66 11.34 32.00 ndc
Wild-type 95.83 4.17 43.32 nd
a Average values of 3 experiments with n = 100 cells each.
b Average values of 2 experiments with n = 100 cells each, normalized to transfection effi ciency. DM is 
differentiation medium.
c Not detectable
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GFP-lamin A staining at the nuclear rim survived to a 
higher extent (table 1). Expression of the early markers 
of differentiation, such as myogenin and cyclin D3, was 
strongly impaired in cells expressing aggregates of G232E, 
Q294P and R386K but nearly normal in cells with peripheral 
GFP-lamin A staining (fi gure 2B,C). To determine whether 
levels of muscle-specifi c regulators such as MyoD were 
altered in proliferating myoblasts, we analysed the effects 
of ectopic expression of lamin constructs on MyoD levels 
by an immunofl uorescence assay. We observed that only 
10–20% of myoblasts transfected with the G232E, Q294P 
or R386K mutants expressed MyoD, whereas ~50% of 
cells transfected with wild-type GFP lamin A or the R482L 
mutant expressed MyoD (fi gure 2D). Moreover, MyoD 
was detectable in only ~50% of untransfected cells due to 
its tight regulation in dividing myoblasts. Expression of 
these mutants in myoblasts did not affect total RNA pol 
II transcription levels (data not shown). Hence dividing 
myoblasts expressing lamin EDMD mutants are clearly 
defi cient in MyoD and this might explain why these cells 
show impaired differentiation. 
The differentiation potential of primary myoblasts 
isolated from lamin A/C knock-out mice has been 
investigated by Frock and colleagues (Frock et al 2006). 
These myoblasts have delayed differentiation kinetics 
and impaired differentiation. Certain markers of muscle 
Figure 2. Characterization of C2C12 cells expressing GFP lamin A constructs. (A) Domain structure of lamin A protein indicating 
disease-causing mutations that have been analysed in our laboratory. (B,C) C2C12 cells were induced to differentiate to multinucleated 
myotubes in serum-depleted medium for 36 h after transient transfection with GFP lamin A constructs for 24 h (green), and stained with 
antibody to myogenin (red) in (B) and cyclin D3 (red) in(C). (D) C2C12 myoblasts were transfected with GFP lamin A constructs (green) 
and stained with antibody to MyoD (red). All samples were counterstained with the DNA dye DAPI (not shown). WT, wild-type GFP lamin 
A; numbers represent GFP lamin A constructs with altered amino acid residues indicated in (A). Bar, 10 µm.
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differentiation such as MyoD and pRb were observed to be 
downregulated at the protein level while the muscle regulator 
Myf5 was upregulated several-fold. Myf5 has been earlier 
shown to be upregulated in mice lacking MyoD (Rudnicki 
et al 1992). Interestingly, levels of the cytoskeletal protein 
desmin were also reduced in ~70% of cells, as observed 
earlier in Lmn−/− cardiomyocytes (Nikolova et al 2004). 
Both MyoD and desmin transcript levels were reduced in 
proliferating Lmn−/− myoblasts but pRb transcript levels were 
normal, suggesting that pRb protein stability was reduced 
in these cells, perhaps due to the absence of lamin A/C as 
a binding partner for pRb. RNAi-mediated silencing of 
lamin A/C expression in myoblasts also caused impaired 
differentiation, and reduction in MyoD and desmin levels. 
Ectopic expression of MyoD or desmin in Lmn−/− myoblasts 
resulted in increased differentiation potential. It is thus 
evident that MyoD levels are sensitive to the presence of 
a normal lamin A network as both depletion of lamin A in 
Lmn−/− myoblasts and overexpression of lamin A constructs, 
in particular the EDMD mutants, can lead to lowering of 
MyoD and impairment of muscle differentiation. Earlier 
studies showing that desmin knock-out mice have post-natal 
defects in muscle development (Li et al 1996) imply that 
desmin is also important for muscle differentiation. Hence 
muscle-specifi c gene expression might involve cross-talk 
between cytoplasmic fi laments and the nuclear skeleton. An 
interesting point to note is that Lmn−/− myoblasts are unable 
to exit the cell cycle and continue to proliferate upon serum 
deprivation. This property of the lamin-defi cient cells is 
in contrast to the loss in survival of myoblasts expressing 
EDMD lamin mutants in serum-depleted medium (Favreau 
et al 2004; this study). A recent transcriptional profi ling of 
EDMD muscle biopsies suggests a failure of interactions 
between envelope proteins and pRb and MyoD during exit 
from the cell cycle (Bakay et al 2006).
We have also been interested in understanding the role 
of nucleoplasmic lamins in the muscle differentiation. 
Our earlier studies have shown that internal lamins are 
antigenically masked and reorganized to a diffuse network 
at an early stage (prior to cell cycle arrest) during the 
differentiation of C2C12 myoblasts in culture (Muralikrishna 
et al 2001). This diffuse network was also observed in 
quiescent, satellite cells but not in non-muscle cell types. In 
further studies, lamin organization was observed to be linked 
to the myogenic programme as it occurred in fi broblasts 
induced to trans-differentiate to muscle cells by MyoD 
expression, but not in other cell types. Lamin speckles 
were induced to rearrange upon expression of cyclin D3 in 
myoblasts and this process also required pRb; both pRb and 
cyclin D3 were sequestered on the insoluble lamin matrix 
(Mariappan and Parnaik 2005). Lamin reorganization 
may thus be required to maintain the post-mitotic state. 
Dominant negative mutants such as an N-terminal deletion 
of lamin A inhibited expression of early markers of muscle 
differentiation such as myogenin and transfected cells were 
not incorporated into myotubes. 
5.3 Effects on adipocyte differentiation
The mutations in LMNA that result in FPLD are clustered 
within the exons encoding the C-terminal domain, 
specifi cally exons 8 and 11. Yeast two-hybrid and in 
vitro binding analysis have shown that this region binds 
specifi cally to SREBP1 (Lloyd et al 2002). SREBPs are 
produced as membrane-bound precursors which reside in the 
ER. Upon reduction in cellular cholesterol levels, SREBP1 
is proteolytically cleaved and imported into the nucleus 
where it directly activates genes involved in cholesterol 
biosynthesis (Brown and Goldstein 1999). SREBP1 has 
been shown to be sequestered by pre-lamin A at the nuclear 
periphery in fi broblasts from lipodystrophy patients, thus 
lowering the pool of active SREBP1 and inhibiting pre-
adipocyte differentiation (Capanni et al 2005). In this 
study, the levels of pre-lamin A were found to be higher in 
lipodystrophy fi broblasts compared to normal fi broblasts. A 
recent report suggests that lamin A may normally act as an 
inhibitor of adipocyte differentiation, as Lmn−/− fi broblasts 
accumulate more intracellular lipid and show elevated 
triglyceride synthesis compared to wild-type fi broblasts, 
and overexpression of both wild-type and mutant lamin A 
inhibits adipocyte differentiation (Boguslavsky et al 2006). 
The authors suggest that mutations causing FPLD might be 
‘gain-of-function’ mutations that result in higher binding 
affi nity to a pro-adipogenic factor, thereby sequestering it 
at the nuclear periphery and inhibiting expression of genes 
involved in adipogenesis. This pro-adipogenic factor might 
correspond to SREBP1, as proposed in the earlier studies 
(Lloyd et al 2002; Capanni et al 2005). Interestingly, 
misexpression of the lamin A-binding protein LAP2α alters 
cell cycle progression and pRb-E2F signalling, and also 
inhibits adipocyte differentiation (Dorner et al 2006). The 
role of a “master repressor” for lamin A in regulating gene 
transcription is supported by a recent report of sequestration 
of c-Fos at the nuclear periphery by lamin A, followed by 
suppression of AP-1 transcriptional activity (Ivorra et al 
2006).
5.4 Effects on DNA repair pathways
Cells have developed complex systems for the repair of 
DNA which has been damaged by external agents such as 
ionizing and UV-irradiation and genotoxic agents, or by 
internal sources such as reactive oxygen species. The initial 
response to DNA damage involves the chromatin-dependent 
activation of complex checkpoint signalling pathways in 
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order to delay the cell cycle and repair the defects. The 
major kinases that serve as damage sensors and regulate 
cell cycle checkpoints and DNA repair by phosphorylation 
of key substrates are Ataxia-telangiectasia-mutated (ATM) 
and ATM-and-Rad3-related (ATR) kinases that belong to 
the phosphoinositide 3-kinase-related family of serine/
threonine protein kinases (reviewed by Zhou and Elledge 
2000; Abraham 2001; Shiloh 2003; Bartek et al 2004). ATM 
and ATR activate cell cycle checkpoints and phosphorylate 
p53 as well as a number of other downstream targets such 
as the histone variant H2AX (Redon et al 2002). Mutations 
in several components of these DNA repair pathways 
cause premature ageing syndromes in humans and cellular 
senescence in cell culture models (Lombard et al 2005). A 
common premature ageing disorder, Werner’s syndrome, 
is caused by loss of a RecQ family DNA helicase, WRN, 
which functions in several DNA repair pathways (Bohr 
2005). As discussed earlier in this review, mutations in 
the lamin A gene are associated with atypical Werner’s 
syndrome (Chen et al 2003) and HGPS (Eriksson et al 2003; 
De Sandre-Giovannoli et al 2003). Deletion of the pre-
lamin A processing enzyme, Zmpste24 in mice also leads 
to a progeria-like syndrome (Pendás et al 2002; Bergo et al 
2002). 
Two recent studies with Zmpste24-null fi broblasts and 
HGPS fi broblasts have demonstrated a link between defects 
in lamin A and the DNA damage response. Zmpste24-null 
fi broblasts showed genomic instability and the mice were 
more sensitive to DNA damaging agents (Liu et al 2005). 
Furthermore, recruitment of repair proteins such as p53 
binding protein 1 (53BP1) and Rad51 to sites of DNA lesions 
was impaired. Chromosomal aneuploidy in HGPS cells has 
been observed previously (Mukherjee and Costello 1998). 
In the second study, an analysis of transcriptional changes 
in Zmpste24-defi cient cells has revealed that several targets 
of the p53 signalling pathway are upregulated, suggesting a 
checkpoint response that is activated by abnormal nuclear 
architecture (Varela et al 2005). An earlier study with HGPS 
fi broblasts has shown changes in gene transcription profi les 
which suggest developmental defects in mesodermal and 
mesenchymal cell lineages (Csoka et al 2004b).
Parnaik and coworkers have examined the early response 
of cells expressing disease-causing lamin A mutants to 
DNA damage induced by cisplatin or UV, which primarily 
cause replicational stress due to stalled replication forks in 
S phase, and observed that several mutants impaired the 
formation of phosphorylated H2AX at DNA repair foci and 
hindered the recruitment of 53BP1 to repair sites. These 
mutants disrupted emerin localization and, importantly, 
also mislocalized ATR kinase in untreated cells (Manju et 
al 2006). Our results suggest that lamin mutants are likely 
to affect the response of the DNA repair machinery to DNA 
damage by altered interactions with chromatin.
6. Conclusions and perspectives
Investigations carried out in the past decade have 
established that lamins, which were considered to be only 
structural elements in the nucleus, have diverse roles in the 
organization of nuclear functions such as DNA replication, 
transcription and repair, in addition to their requirement for 
nuclear integrity. Observations that the mutations in human 
LMNA are associated with the group of highly degenerative 
genetic disorders termed laminopathies have contributed 
signifi cantly towards understanding the role of lamins. 
Valuable insights into the role of lamins in tissue-specifi c 
signalling pathways have been obtained by analysis of animal 
models as well as in vitro differentiation models, although 
the potential limitations of these models in interpretation 
for diseases in humans need to be kept in mind. Important 
aspects of lamin biology that need further investigation 
include the precise role of lamins in the organization of DNA 
replication, transcription and repair, the mode of interaction 
of lamins with chromatin and the mechanism of formation of 
higher order assemblies of lamins.
From an analysis of the recent literature, it is becoming 
increasingly evident that disease-causing mutations in 
lamin A/C may be considered to be dominant negative 
mutations that lead to cellular toxicity and cell death. One 
line of possible therapies for HGPS is the use of inhibitors to 
reduce the amount of toxic farnesylated pre-lamin A (Fong 
et al 2006a). Since loss of lamin A is not detrimental in the 
mouse (Fong et al 2006b), the accompanying loss in mature 
lamin A might not be harmful. An intriguing fi nding is the 
accumulation of progerin and accompanying nuclear defects 
in cells from old individuals, which raises the possibility 
that normal ageing might be due to aberrations in nuclear 
architecture.
A crucial question that has not yet been answered 
satisfactorily is why do different mutations in LMNA cause 
such diverse pathologies. A possible clue has come from 
studies on the FPLD mutations, which appear to disrupt the 
functions of SREBP1, a tissue-specifi c transcription factor 
that plays an essential role in adipocyte differentiation. Do 
other mutations perturb the functions of other tissue-specifi c 
factors and thus affect distinct tissues? MyoD expression is 
clearly altered by downregulation of lamin A or expression 
of EDMD mutations but not by FPLD mutations. However, 
the exact role of lamin A in the expression of MyoD is not 
yet clear. Though initial analysis of patients had suggested 
that most mutations affected only specifi c tissues such as 
muscle or adipose tissue, recent reports indicate that some 
mutations may cause overlapping disease symptoms. Do 
such mutations affect interactions with more than one 
transcription factor? Furthermore, progeroid features appear 
to accompany several disorders. Do lamin mutations have 
pleiotropic effects on DNA repair pathways? Some of these 
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aspects are under active investigation by several groups, and 
hopefully a unifying explanation for this intriguing aspect of 
laminopathies would be forthcoming soon.
Acknowledgements
We thank Durgadas Kasbekar for helpful comments on the 
manuscript and Indumathi Mariappan for providing fi gure 1. 
Financial support of the Department of Biotechnology and 
Council of Scientifi c and Industrial Research, New Delhi for 
this work is gratefully acknowledged. KM was supported by 
a senior research fellowship from the Council of Scientifi c 
and Industrial Research.
References
Abraham R T 2001 Cell cycle checkpoint signalling through the 
ATM and ATR kinases; Genes Dev. 15 2177–2196
Agarwal A K, Fryns J P, Auchus R J and Garg A 2003 Zinc 
metalloproteinase, ZMPSTE24, is mutated in mandibuloacral 
dysplasia; Hum. Mol. Genet. 12 1995–2001
Arimura T, Helbling-Leclerc A, Massart C, Varnous S, Niel F. 
Lacène E, Fromes Y, Toussaint M, Mura A, Keller D I et al 
2005 Mouse model carrying H222P-Lmna mutation develops 
muscular dystrophy and dilated cardiomyopathy similar to 
human striated muscle laminopathies; Hum. Mol. Genet. 14 
155–169
Bakay M, Wang Z, Melcon G, Schiltz L, Xuan J, Zhao P,
Sartorelli V, Seo J, Pegoraro E, Angelini C et al 2006 Nuclear 
envelope dystrophies show a transcriptional fi ngerprint 
suggesting disruption of Rb-MyoD pathways in muscle 
regeneration; Brain 129 996–1013
Bartek J, Lukas C and Lukas J 2004 Checking on DNA damage in 
S phase; Nature (London) 5 792–804
Bechert K, Lagos-Quintana M, Harborth J, Weber K and Osborn 
M 2003 Effects of expressing lamin A mutant protein causing 
Emery-Dreifuss muscular dystrophy and familial partial 
lipodystrophy in HeLa cells; Exp. Cell Res. 286 75–86
Benedetti S, Bertini E, Iannaccone S, Angelini C, Trisciani M, 
Toniolo D, Sferrazza B, Carrera P, Comi G, Ferrari M et al 2005 
Dominant LMNA mutations can cause combined muscular 
dystrophy and peripheral neuropathy; J. Neurol. Neurosurg. 
Psychiatry 76 1019–1021
Bergo M O, Gavino B, Ross J, Schmidt W K, Hong C, Kendall L 
V, Mohr A, Meta M, Genant H, Jiang Y et al 2002 Zmpste24 
defi ciency in mice causes spontaneous bone fractures, muscle 
weakness, and a pre-lamin A processing defect; Proc. Natl. 
Acad. Sci. USA 99 13049–13054
Bione S, Maestrini E, Rivella S, Mancini M, Regis S, Romeo G 
and Toniolo D 1994 Identifi cation of a novel X-linked gene 
responsible for Emery-Dreifuss muscular dystrophy; Nat. 
Genet. 8 323–327
Boguslavsky R L, Stewart C L and Worman H J 2006 Nuclear 
lamin A inhibits adipocyte differentiation: implications for 
Dunnigan-type familial partial lipodystrophy; Hum. Mol. Genet. 
15 653–663
Bohr V A 2005 Defi cient DNA repair in the human progeroid 
disorder, Werner syndrome; Mutat. Res. 577 252–259
Bonne G, Di Barletta M R, Varnous S, Becane H M, Hammonda 
E H, Merlini L, Muntoni F, Greenberg C R, Gary F, Urtizberea 
J A et al 1999 Mutations in the gene encoding lamin A/C cause 
autosomal dominant Emery-Dreifuss muscular dystrophy; Nat. 
Genet. 21 285–288 
Bonne G, Mercuri E, Muchir A, Urtiziberea A, Becane H M,
Reca D, Merlini L, Wehnert M, Boor R, Reuner U et al 2000 
Clinical and molecular genetic spectrum of autosomal dominant 
Emery Dreifuss muscular dystrophy due to mutations of the 
lamin A/C gene; Ann. Neurol. 48 170–180
Broers J L V, Kuijpers H J H, Östlund C, Worman H J, Endert J 
and Ramaekers F C S 2005 Both lamin A and lamin C mutations 
cause lamina instability as well as loss of internal nuclear lamin 
organization; Exp. Cell Res. 304 582–592
Broers J L, Machiels B M, van Eys G J, Kuijpers H J, Manders 
E M, van Driel R and Ramaekers F C 1999 Dynamics of the 
nuclear lamina as monitored by GFP-tagged A-type lamins;
J. Cell Sci. 112 3463–3475
Broers J L, Peeters E A, Kuijpers H J, Endert J, Bouten C V, 
Oomens C W, Baaijens F P and Ramaekers F C 2004 Decreased 
mechanical stiffness in LMNA–/– cells is caused by defective 
nucleo-cytoskeletal integrity: Implications for the development 
of laminopathies; Hum. Mol. Genet. 13 2567–2580 
Brown M S and Goldstein J L 1999 A proteolytic pathway that 
controls the cholesterol content of membranes, cells and blood; 
Proc. Natl. Acad. Sci. USA 96 11041–11048
Brown C A, Lanning R W, McKinney K Q, Salvino A R, Cherniske 
E, Crowe C A, Darras B T, Gominak S, Greenberg C R, 
Grosmann C et al 2001 Novel and recurrent mutations in lamin 
A/C in patients with Emery–Dreifuss muscular Dystrophy; Am. 
J. Med. Genet. 102 359–367
Capanni C, Cenni V, Mattioli E, Sabatelli P, Ognibene A, Columbaro 
M, Parnaik V K, Wehnert M, Maraldi N M, Squarzoni S and 
Lattanzi G 2003 Failure of lamin A/C to functionally assemble 
in R482L mutated familial partial lipodystrophy fi broblasts: 
Altered intermolecular interaction with emerin and implications 
for gene transcription; Exp. Cell Res. 291 122–134
Capanni C, Mattioli E, Columbaro M, Lucarelli E, Parnaik V K, 
Novelli G, Wehnert M, Cenni V, Maraldi N M, Squarzoni S and 
Lattanzi G 2005 Altered pre-lamin A processing is a common 
mechanism leading to lipodystrophy; Hum. Mol. Genet. 14 
1489–1502
Cao H and Hegele R A 2000 Nuclear lamin A/C R482Q mutation 
in Canadian kindreds with Dunnigan-type familial partial 
lipodystrophy; Hum. Mol. Genet. 9 109–112
Cao H and Hegele R A 2003 LMNA is mutated in Hutchinson-
Gilford progeria (MIM 176670) but not in Wiedemann-
Rautenstrauch progeroid syndrome (MIM 264090); J. Hum. 
Genet. 48 271–274
Capell B C, Erdos M R, Madigan J P, Fiordalisi J J, Varga R, 
Conneely K N, Gordon L B, Der C J, Cox A D and Collins 
F S 2005 Inhibiting farnesylation of progerin prevents the 
characteristic nuclear blebbing of Hutchinson-Gilford progeria 
syndrome; Proc. Natl. Acad. Sci. USA 102 12879–12884
Caux F, Dubosclard E, Lascols O, Buendia B, Chazouilleres O, 
Cohen A, Courvalin J-C, Laroche L, Capeau J, Vigouroux C and 
Nuclear lamins and disease 417
J. Biosci. 31(3), September 2006
Christin-Maitre S 2003 A new clinical condition linked to a novel 
mutation in lamins A and C with generalized lipoatrophy, insulin 
resistant diabetes, disseminated leukomelanodermic papules, 
liver steatosis, and cardiomyopathy; J. Clin. Endocrinol. Metab. 
88 1006–1013
Chen I, Lee I, Kudlow B A, Dos Santos H G, Stervoid O, 
Shafeghati Y, Botha E G, Garg A, Hanson N B, Martin G M 
et al 2003 LMNA mutations in atypical Werner’s syndrome; 
Lancet 362 440–445
Cohen M, Lee K K, Wilson K L and Gruenbaum Y 2001 
Transcriptional repression, apoptosis, human disease and the 
functional evolution of the nuclear lamina; Trends Biochem. 
Sci. 26 41–47
Columbaro M, Capanni C, Mattioli E, Novelli G, Parnaik V K, 
Squarzoni S, Maraldi N M and Lattanzi G 2005 Rescue of 
heterochromatin organization in Hutchinson-Gilford progeria 
by drug treatment; Cell. Mol. Life Sci. 62 2669–2678
Csoka A B, Cao H, Sammak P J, Constantinescu D, Schatten 
G P and Hegele R A 2004a Novel lamin A/C gene (LMNA) 
mutations in atypical progeroid syndromes; J. Med. Genet. 41 
304–308
Csoka A B, English S B, Simkevich C P, Ginzinger D G, Butte A 
J, Schatten G P, Rothman F G and Sedivy J M 2004b Genome-
scale expression profi ling of Hutchinson-Gilford progeria 
syndrome reveals widespread transcriptional misregulation 
leading to mesodermal/mesenchymal defects and accelerated 
atherosclerosis; Aging Cell 3 235–243 
de la Luna S, Allen K E, Mason S L and La Thangue N B 1999 
Integration of a growth-suppressing BTB/POZ domain protein 
with the DP component of the E2F transcription factor; EMBO 
J. 18 212–228
De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, 
Boccaccio I, Lyonnet S, Stewart C I, Munnich A, Le Merrer M 
and Levy N 2003 Lamin A truncation in Hutchinson-Gilford 
progeria; Science 300 2055 
De Sandre-Giovannoli A, Chaouch M, Kozlov S, Vallat J M, Tazir 
M, Kassouri N, Szepetowski P, Hammadouche T, Vandenberghe 
A, Stewart C L et al 2002 Homozygous defects in LMNA, 
encoding lamin A/C nuclear-envelope proteins, cause autosomal 
recessive axonal neuropathy in human (Charcot-Marie-Tooth 
disorder type 2) and mouse; Am. J. Hum. Genet. 70 726–736
Dechat T, Korbei B, Vaughan O A, Vlcek S, Hutchison C J and 
Foisner R 2000 Lamina-associated polypeptide 2α binds 
intranuclear A-type lamins; J. Cell Sci. 113 3473–3484
Dhe-Paganon S, Werner E D, Chi Y and Shoelson S E 2002 
Structure of the globular tail of nuclear lamin; J. Biol. Chem. 
277 17381–17384
Dorner D, Vlcek S, Foeger N, Gajewski A, Makolm C, 
Gotzmann J, Hutchison C J and Foisner R 2006 Lamina-
associated polypeptide 2α regulates cell cycle progression and 
differentiation via the retinoblastoma-E2F pathway; J. Cell Biol. 
173 83–93
Dreuillet C, Tillit J, Kress M and Ernoult-Lange M 2002 In vivo
and in vitro interaction between human transcription factor 
MOK2 and nuclear lamin A/C; Nucleic Acids Res. 30
4634–4642 
Ellis D J, Jenkins H, Whitfi eld W G F and Hutchison C J 1997 
GST-lamin fusion proteins act as dominant negative mutants in 
Xenopus egg extract and reveal the function of the lamina in 
DNA replication; J. Cell Sci. 110 2507–2518
Emery A E and Dreifuss F E 1966 Unusual type of benign X-
linked muscular dystrophy; J. Neurol. Neurosurg. Psychiatry 
29 338–342
Eriksson M, Brown W T, Gordon L B, Glynn M W, Singer J, Scott 
L, Erdos M R, Robbins C M, Moses T Y, Berglund P et al 2003 
Recurrent de novo point mutations in lamin A cause Hutchinson-
Gilford progeria syndrome; Nature (London) 423 293–298
Fatkin D, MacRae C, Sasaki T, Wolff M R, Porcu M, Frenneaux M, 
Atherton J, Vidaillet H J Jr, Spudich S, De Girolami U et al 1999 
Missense mutations in the rod domain of the lamin A/C gene 
as causes of dilated cardiomyopathy and conduction-system 
disease; New Engl. J. Med. 341 1715–1724 
Favreau C, Dubosclard E, Östlund C, Vigouroux C, Capeau J, 
Wehnert M, Higuet D, Worman H J, Courvalin J C and Buendia 
B 2003 Expression of lamin A mutated in the carboxyl-terminal 
tail generates an aberrant nuclear phenotype similar to that 
observed in cells from patients with Dunnigan-type partial 
lipodystrophy and Emery-Dreifuss muscular dystrophy; Exp 
Cell Res. 282 14–23
Favreau C, Higuet D, Courvalin J-C and Buendia B 2004 
Expression of a mutant lamin A that causes Emery-Dreifuss 
muscular dystrophy inhibits in vitro differentiation of C2C12 
myoblasts; Mol. Cell. Biol. 24 1481–1492
Fawcett D W 1966 On the occurrence of a fi brous lamina on 
the inner aspect of the nuclear envelope in certain cells of 
vertebrates; Am. J. Anat. 119 129–145
Fong L G, Frost D, Meta M, Qiao X, Yang S H, Coffi nier C 
and Young S G 2006a A protein farnesyltransferase inhibitor 
ameliorates disease in a mouse model of progeria; Science 311 
1621–1623
Fong L G, Ng J K, Lammerding J, Vickers T A, Meta M, Coté N, 
Gavino B, Qiao X, Chang S Y, Young S R et al 2006b Prelamin 
A and lamin A appear to be dispensable in the nuclear lamina; J. 
Clin. Invest. 116 743–752
Frock R L, Kudlow B A, Evans A M, Jameson S A, Hauschka S 
D and Kennedy B K 2006 Lamin A/C and emerin are critical 
for skeletal muscle satellite cell differentiation; Genes Dev. 20 
486–500
Gant T M and Wilson K L 1997 Nuclear assembly; Annu. Rev. Cell 
Dev. Biol. 13 669–695
Garg A, Speckman R A and Bowcock A M 2002 Multisystem 
dystrophy syndrome due to novel missense mutations in the 
amino-terminal head and alpha-helical rod domains of the lamin 
A/C gene; Am. J. Med. 112 549–555
Gerasimova T I and Corces V G 1998 Polycomb and trithorax 
group proteins mediate the function of a chromatin insulator; 
Cell 92 511–521 
Gilchrist S, Gilbert N, Perry P, Östlund C, Worman H J and 
Bickmore W A 2004 Altered protein dynamics of disease-
associated lamin A mutants; BMC Cell Biol. 5 46
Glynn M W and Glover T W 2005 Incomplete processing of 
mutant lamin A in Hutchinson-Gilford progeria leads to nuclear 
abnormalities, which are reversed by farnesyltransferase 
inhibition; Hum. Mol. Genet. 14 2959–2969
Goizet C, Yaou R B, Demay L, Richard P, Bouillot S, Rouanet 
M, Hermosilla E, Le Masson G, Lagueny A, Bonne G
Veena K Parnaik and Kaliyaperumal Manju418
J. Biosci. 31(3), September 2006
and Ferrer X 2004 A new mutation of the lamin A/C gene
leading to autosomal dominant axonal neuropathy, muscular 
dystrophy, cardiac disease, and leuconychia; J. Med. Genet. 
41 e29
Goldman R D, Gruenbaum Y, Moir R D, Shumaker D K and 
Spann T P 2002 Nuclear lamins: Building blocks of nuclear 
architecture; Genes Dev. 16 533–547
Goldman A E, Moir R D, Montag-Lowy M, Stewert M and 
Goldman R D 1992 Pathway of incorporation of microinjected 
lamin A into the nuclear envelope; J. Cell Biol. 119 725–735
Goldman R D, Shumaker D K, Erdos M R, Eriksson M, Goldman 
A E, Gordon L B, Gruenbaum Y, Khuon S, Mendez M, Varga R 
and Collins F S 2004 Accumulation of mutant lamin A causes 
progressive changes in nuclear architecture in Hutchinson-
Gilford progeria syndrome; Proc. Natl. Acad. Sci. USA 101 
8963–8968
Gruenbaum Y, Margalit A, Goldman R D, Shumaker D K and 
Wilson K L 2005 The nuclear lamina comes of age; Nat. Rev. 
Mol. Cell. Biol. 6 21–31
Guillemin K, Williams T and Krasnow M A 2001 A nuclear lamin 
is required for cytoplasmic organisation and egg polarity in 
Drosophila; Nat. Cell Biol. 3 848–851
Haithcock E, Dayani Y, Neufeld E, Zahand A J, Feinstein N, 
Mattout A, Gruenbaum Y and Liu J 2005 Age-related changes 
of nuclear architecture in Caenorhabditis elegans; Proc. Natl. 
Acad. Sci. USA 102 16690–16695 
Hellemans J, Preobrazhenska O, Willaert A, Debeer P, Verdonk P 
C M, Costa T, Janssens K, Menten B, Van Roy N, Vermeulen 
S J T et al 2004 Loss-of-function mutations in LEMD3 
result in osteopoikilosis, Buschke-Ollendorff syndrome and 
melorheostosis; Nat. Genet. 36 1213–1218
Hoffman K, Dreger C K, Olins A L, Olins D E, Shultz L D, Lucke 
B, Karl H, Kaps R, Muller D, Vaya A et al 2002 Mutations 
in the gene encoding the lamin B receptor produce an altered 
nuclear morphology in granulocytes (Pelger-Huet anomaly); 
Nat. Genet. 31 410–414
Hozák P, Sasseville A M-J, Raymond Y and Cook P R 1995 Lamin 
proteins form an internal nucleoskeleton as well as a peripheral 
lamina in human cells; J. Cell Sci. 108 635–644
Huang S, Chen L, Libina N, Janes J, Martin G M, Campisi J 
and Oshima J 2005 Correction of cellular phenotypes of 
Hutchinson-Gilford Progeria cells by RNA interference; Hum. 
Genet. 118 444–450
Hutchison C J and Worman H J 2004 A-type lamins: Guardians of 
the soma?; Nat. Cell Biol. 6 1062–1067
Imai S, Nishibayashi S, Takao K, Tomifuji M, Fujino T, 
Hasegawa M and Takano T 1997 Dissociation of Oct-1 from 
the nuclear peripheral structure induces the cellular aging-
associated collagenase gene expression; Mol. Biol. Cell 8 
2407–2419 
Ivorra C, Kubicek M, González J M, Sanz-González S M, Álvarez-
Barrientos A, O’Connor J-E, Burke B and Andrés V 2006 A 
mechanism of AP-1 suppression through interaction of c-Fos 
with lamin A/C; Genes Dev. 20 307–320
Jacob K N and Garg A 2006 Laminopathies: Multisystem dystrophy 
syndromes; Mol. Genet. Metab. 87 289–302
Jagatheesan G, Thanumalayan S, Muralikrishna Bh, Rangaraj 
N, Karande A A and Parnaik V K 1999 Colocalisation of 
intranuclear lamin foci with RNA splicing factors; J. Cell Sci. 
112 4651–4661
Karabinos A, Schunemann J, Meyer M, Aebi U and Weber K 2003 
The single nuclear lamin of Caenorhabditis elegans forms 
in vitro stable intermediate fi laments and paracrystals with a 
reduced axial periodicity; J. Mol. Biol. 325 241–247
Kennedy B K, Barbie D A, Classon M, Dyson N and Harlow 
E 2000 Nuclear organisation of DNA replication in primary 
mammalian cells; Genes Dev. 14 2855–2868
Kirschner J, Brune T, Wehnert M, Denecke J, Wasner C, Feuer A, 
Marquardt T, Ketelsen U P, Wieacker P, Bonnemann C G and 
Korinthenberg R 2005 p.S143F mutation in lamin A/C: A new 
phenotype combining myopathy and progeria; Ann. Neurol. 57 
148–151 
Kumaran R I, Muralikrishna Bh and Parnaik V K 2002 Lamin 
A/C speckles mediate spatial organisation of splicing factor 
compartments and RNA polymerase II transcription; J. Cell 
Biol. 159 783–793
Lammerding J, Schulze P C, Takahashi T, Kozlov S, Sullivan T, 
Kamm R D, Stewart C L and Lee R T 2004 Lamin A/C defi ciency 
causes defective nuclear mechanics and mechanotransduction; 
J. Clin. Invest. 113 370–378
Lenz-Bohme B, Wismar J, Fuchs S, Reifegerste R, Buchner E, Betz 
H and Schmitt B 1997 Insertional mutation of the Drosophila 
nuclear lamin Dm
0
 gene results in defective nuclear envelopes, 
clustering of nuclear pore complexes, and accumulation of 
annulate lamellae; J. Cell Biol. 137 1001–1016
Li Z, Colucci-Guyon E, Pincon-Raymond M, Mericskay M, 
Pournin S, Paulin D and Babinet C 1996 Cardiovascular lesions 
and skeletal myopathy in mice lacking desmin; Dev. Biol. 175 
362–366
Liu J, Ben-Shahar T R, Riemer D, Treinin M, Spann P, Weber 
K, Fire A and Gruenbaum Y 2000 Essential roles for 
Caenorhabditis elegans lamin gene in nuclear organization, 
cell cycle progression, and spatial organization of nuclear pore 
complexes; Mol. Biol. Cell 11 3937–3947 
Liu B, Wang J, Chan K M, Tjia W M, Deng W, Guan X,
Huang J D, Li K M, Chau P Y, Chen D J et al 2005 Genomic 
instability in laminopathy-based premature aging; Nat Med. 11 
780–785
Lloyd D J, Trembath R C and Shackleton S 2002 A novel 
interaction between lamin A and SREBP1: implications for 
partial lipodystrophy and other laminopathies; Hum. Mol. 
Genet. 11 769–777
Lombard D B, Chua K F, Mostoslavsky R, Franco S, Gostissa M 
and Alt F W 2005 DNA repair, genome stability and aging; Cell 
120 497–512
Mallampalli M P, Huyer G, Bendale P, Gelb M H and Michaelis S 
2005 Inhibiting farnesylation reverses the nuclear morphology 
defect in a HeLa cell model for Hutchinson-Gilford progeria 
syndrome; Proc. Natl. Acad. Sci. USA 102 14416–14421
Mancini M A, Shan B, Nickerson J A, Penman S and Lee W H 
1994 The retinoblastoma gene product is a cell cycle-dependent, 
nuclear matrix-associated protein; Proc. Natl. Acad. Sci. USA 
91 418–422
Manilal S, Nguyen T M, Sewry C A and Morris G E 1996 The 
Emery-Dreifuss muscular dystrophy protein, emerin, is a 
nuclear membrane protein; Hum. Mol. Genet. 5 801–808 
Nuclear lamins and disease 419
J. Biosci. 31(3), September 2006
Manju K, Muralikrishna Bh and Parnaik V K 2006 Expression of 
disease-causing lamin mutants impairs the formation of DNA 
repair foci; J. Cell Sci. 119 2704–2714
Markiewicz E, Dechat T, Foisner R, Quinlan R A and Hutchison 
C J 2002 Lamin A/C binding protein LAP2α is required for 
nuclear anchorage of retinoblastoma protein; Mol. Biol Cell 13 
4401–4413
Markiewicz E, Ledran M and Hutchison C J 2005 Remodelling of 
the nuclear lamina and nucleoskeleton is required for skeletal 
muscle differentiation in vitro; J. Cell Sci. 118 409–420
Mariappan I and Parnaik V K 2005 Sequestration of pRb by cyclin 
D3 causes intranuclear reorganization of lamin A/C during 
muscle cell differentiation; Mol. Biol. Cell 16 1948–1960 
Mattout A, Dechat T, Adam S A, Goldman R D and Gruenbaum Y 
2006 Nuclear lamins, diseases and aging; Curr. Opin. Cell Biol 
18 1–7
McClintock D, Gordon L B and Djabali K 2006 Hutchinson-Gilford 
progeria mutant lamin A primarily targets human vascular cells 
as detected by an anti-lamin A G608G antibody; Proc. Natl. 
Acad. Sci. USA 103 2154–2159
Meier J, Campbell K H, Ford C C, Stick R and Hutchison C J
1991 The role of lamin LIII in nuclear assembly and DNA 
replication, in cell free extracts of Xenopus eggs; J. Cell Sci. 
98 271–279
Meune C, Van Berlo J H, Anselme F, Bonne G, Pinto Y M
and Duboc D 2006 Primary prevention of sudden death in 
patients with lamin A/C gene mutations; N. Engl. J. Med. 354 
209–210
Mintz P J, Patterson S D, Neuwald A F, Spahr C S and Spector 
D L 1999 Purifi cation and biochemical characterisation of 
interchromatin granule clusters; EMBO J. 18 4308–4320
Mislow J M K, Kim M S, Davis D B and McNally E M 2002 Myne-
1, a spectrin repeat transmembrane protein of the myocyte inner 
nuclear membrane interacts with lamin A/C; J. Cell Sci. 115 
61–70
Moir R D, Montag-Lowy M and Goldman R D 1994 Dynamic 
properties of nuclear lamins: lamin B is associated with sites of 
DNA replication; J. Cell Biol. 125 1201–1212
Moir R D, Spann T P, Herrmann H and Goldman R D 2000a 
Disruption of nuclear lamin organisation blocks the elongation 
phase of DNA replication; J. Cell Biol. 149 1179–1192
Moir R D, Yoon M, Khuon S and Goldman R D 2000b Nuclear 
lamins A and B1: Different pathways of assembly during nuclear 
envelope formation in living cells; J. Cell Biol. 151 1155–1168
Mounkes I C, Kozlov S, Hernandez I, Sullivan T and Stewart
C I 2003 A progeroid syndrome in mice is caused by defects in
A-type lamins; Nature (London) 423 298–301
Mounkes L C, Kozlov S V, Rottman J N and Stewart C L 2005 
Expression of a LMNA-N195K variant of A-type lamins results 
in cardiac conduction defects and death in mice; Hum. Mol. 
Genet. 14 2167–2180
Muchir A, Bonne G, van der Kooi A J, van Meegan M, Baas F, 
Bolhuis P A, de Visser M and Schwartz K 2000 Identifi cation 
of mutations in the gene encoding lamins A/C in autosomal 
dominant limb girdle muscular dystrophy with atrioventricular 
conduction disturbances; Hum. Mol. Genet. 9 1453–1459 
Muchir A, Medioni J, Laluc M, Massart C, Arimura T, van der 
Kooi A J, Desguerre I, Mayer M, Ferrer X, Briault S et al 2004 
Nuclear envelope alterations in fi broblasts from patients with 
muscular dystrophy, cardiomyopathy, and partial lipodystrophy 
carrying lamin A/C gene mutations; Muscle Nerve 30 444–450
Muchir A, van Engelen B G, Lammens M, Mislow J M, McNally 
E, Schwartz K and Bonne G 2003 Nuclear envelope alterations 
in fi broblasts from LGMD1B patients carrying nonsense Y259X 
heterozygous or homozygous mutation in lamin A/C gene; Exp. 
Cell Res. 291 352–362
Mukherjee A B and Costello C 1998 Aneuploidy analysis in 
fi broblasts of human premature aging syndromes by FISH 
during in vitro cellular aging; Mech. Ageing Dev. 103 209–222
Muralikrishna Bh, Dhawan J, Rangaraj N and Parnaik V K 2001 
Distinct changes in intranuclear lamin A/C organisation during 
myoblast differentiation; J. Cell Sci. 114 4001–4011
Nagano A, Koga R, Ogawa M, Kurano Y, Kawada J, Okada 
R, Hayashi Y K, Tsukahara T and Arahata K 1996 Emerin 
defi ciency at the nuclear membrane in patients with Emery-
Dreifuss muscular dystrophy; Nat. Genet. 12 254–259 
Navarro C L, Cadinanos J, De Sandre-Giovannoli A, Bernard 
R, Courrier S, Boccaccio I, Boyer A, Kleijer W J, Wagner A, 
Giuliano F et al 2005 Loss of ZMPSTE24 (FACE-1) causes 
autosomal recessive restrictive dermopathy and accumulation 
of Lamin A precursors, Hum. Mol. Genet. 14 1503–1513
Navarro C, De Sandre-Giovannoli A, Bernard R, Boccaccio I, 
Boyer A, Genevieve D, Hadj-Rabia S, Gaudy-Marqueste C, 
Smith H S, Vabres P et al 2004 Lamin A and ZMPSTE24 
(FACE-1) defects cause nuclear disorganization and identify 
restrictive dermopathy as a lethal neonatal laminopathy; Hum. 
Mol. Genet. 13 2493–2503
Newport J W, Wilson K L and Dunphy W G 1990 A lamin-
independent pathway for nuclear envelope assembly; J. Cell 
Biol. 111 2247–2259 
Nikolova V, Leimena C, McMahon A C, Tan J C, Chandar S, Jogia 
D, Kesteven S H, Michalicek J, Otway R, Verheyen F et al 
2004 Defects in nuclear structure and function promote dilated 
cardiomyopathy in lamin A/C-defi cient mice; J. Clin. Invest. 
113 357–369
Nili E, Cojocaru G S, Kalma Y, Ginsberg D, Copeland N G, Gilbert 
D J, Jenkins N A, Berger R, Shaklai S, Amariglio N et al 2001 
Nuclear membrane protein LAP2β mediates transcriptional 
repression alone and together with its binding partner GCL 
(germ-cell-less); J. Cell Sci. 114 3297–3307
Novelli G, Muchir A, Sangiuolo F, Helbling-Leclerc A, D’Apice 
M R, Massart C, Capon F, Sbraccia P, Federici M, Lauro R
et al 2002 Mandibuloacral dysplasia is caused by a mutation in 
LMNA encoding lamins A/C; Am. J. Hum. Genet. 71 426–431
Osouda S, Nakamura Y, Saint Phalle B, McConnell M, Horigome 
T, Sugiyama S, Fisher P A and Furukawa K 2005 Null 
mutants of Drosophila B-type lamin Dm
0
 show aberrant tissue 
differentiation rather than obvious nuclear shape distortion 
or specifi c defects during cell proliferation; Dev. Biol. 284 
219–232
Östlund C, Bonne G, Schwartz K and Worman H J 2001 Properties 
of lamin A mutants found in Emery-Dreifuss muscular dystrophy, 
cardiomyopathy and Dunnigan-type partial lipodystrophy; J. 
Cell Sci. 114 4435–4445
Ozaki T, Saijo M, Murakami K, Enomoto H, Taya Y and 
Sakiyama S 1994 Complex formation between lamin A
Veena K Parnaik and Kaliyaperumal Manju420
J. Biosci. 31(3), September 2006
and the retinoblastoma gene product: identifi cation of the 
domain on lamin A required for its interaction; Oncogene 9 
2649–2653
Padmakumar V C, Libotte T, Lu W, Zaim H, Abraham S, Noegel 
A A, Gotzmann J, Foisner R and Karakesisoglou I 2005
The inner nuclear membrane protein Sun1 mediates the 
anchorage of Nesprin-2 to the nuclear envelope; J. Cell Sci. 118 
3419–3430
Patterson K, Molofsky A B, Robinson C, Acosta S, Cater C and 
Fischer J A 2004 The functions of Klarsicht and nuclear lamin in 
developmentally regulated nuclear migrations of photoreceptor 
cells in the Drosophila eye; Mol. Biol. Cell 15 600–610
Pendás A M, Zhou Z, Cadiñanos J, Freije J M P, Wang J, Hultenby 
K, Astudillo A, Wernerson A, Rodriguez F, Tryggvason K 
and López-Otin C 2002 Defective prelamin A processing 
and muscular and adipocyte alterations in Zmpste24 
metalloproteinase-defi cient mice; Nat. Genet. 31 94–99
Plasilova M, Chattopadhyay C, Pal P, Schaub N A, Buechner 
S A, Mueller H, Miny P, Ghosh A and Heinimann K 2004 
Homozygous missense mutation in the lamin A/C gene causes 
autosomal recessive Hutchinson–Gilford progeria syndrome;
J. Med. Genet. 41 609–614 
Raffaele Di Barletta M, Ricci E, Galluzzi G, Tonali P, Mora M, 
Morandi L, Romorini A, Voit T, Orstavik K H, Merlini L et al 
2000 Different mutations in the LMNA gene cause autosomal 
dominant and autosomal recessive Emery–Dreifuss muscular 
dystrophy; Am. J. Hum. Genet. 66 1407–1412
Raharjo W H, Enarson P, Sullivan T, Stewart C L and Burke B 2001 
Nuclear envelope defects associated with LMNA mutations 
cause dilated cardiomyopathy and Emery-Dreifuss muscular 
dystrophy; J. Cell Sci. 114 4447–4457
Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K and 
Bonner W 2002 Histone H2A variants H2AX and H2AZ; Curr. 
Opin. Genet. Dev. 12 162–169
Riemer D, Stuurman N, Berrios M, Hunter C, Fisher P A and Weber 
K 1995 Expression of Drosophila lamin C is developmentally 
regulated: analogies with vertebrate A-type lamins; J. Cell Sci. 
108 3189–3198
Röber R A, Weber K and Osborn M 1989 Differential timing 
of nuclear lamin A/C expression in the various organs of the 
mouse embryo and the young animal: a developmental study; 
Development 105 365–378
Rudnicki M A, Braun T, Hinuma S and Jaenisch R 1992 
Inactivation of MyoD in mice leads to upregulation of the 
myogenic HLH gene Myf-5 and results in apparently normal 
muscle development; Cell 71 383–390
Sanna T, Dello Russo A, Toniolo D, Vytopil M, Pelargonio G,
De Martino G, Ricci E, Silvestri G, Giglio V, Messano L
et al 2003 Cardiac features of Emery–Dreifuss muscular 
dystrophy caused by lamin A/C gene mutations; Eur. Heart J. 
24 2227–2236
Scaffi di P and Misteli T 2005 Reversal of the cellular phenotype 
in the premature aging disease Hutchinson-Gilford progeria 
syndrome; Nat. Med. 11 440–445
Scaffi di P and Misteli T 2006 Lamin A-dependent nuclear defects 
in human aging; Science 312 1059–1063
Schulze S R, Curio-Penny B, Li Y, Imani R A, Rydberg L, Geyer 
P K and Wallrath L L 2005 Molecular genetic analysis of the 
nested Drosophila melanogaster Lamin C gene; Genetics 171 
185–196
Shackleton S, Lloyd D J, Jackson S N J, Evans R, Niermeijer
M F, Singh B M, Schmidt H, Brabant G, Kumar S,
Durrington P N et al 2000 LMNA, encoding lamin A/C, is 
mutated in partial lipodystrophy; Nat. Genet. 24 153–156
Shackleton S, Smallwood D T, Clayton P, Wilson L C, Agarwal A 
K, Garg A and Trembath R C 2005 Compound heterozygous 
ZMPSTE24 mutations reduce prelamin A processing and result 
in a severe progeroid phenotype; J. Med. Genet. 42 e36
Shiloh Y 2003 ATM and related protein kinases: safeguarding 
genome integrity; Nat. Rev. Cancer 3 155–168
Shumaker D K, Kuczmarski E R and Goldman R D 2003 The 
nucleoskeleton: lamins and actin are major players in essential 
nuclear functions; Curr. Opin. Cell Biol. 15 358–366
Smith E D, Kudlow B A, Frock R L and Kennedy B K 2005
A-type nuclear lamins, progerias and other degenerative 
disorders; Mech. Ageing Dev. 126 447–460
Spann T P, Goldman A E, Wang C, Huang S and Goldman R D 
2002 Alteration of nuclear lamin organisation inhibits RNA 
polymerase II-dependent transcription; J. Cell Biol. 156 
603–608
Spann T P, Moir R D, Goldman A E, Stick, R and Goldman R 
D 1997 Disruption of nuclear lamin organisation alters the 
distribution of replication factors and inhibits DNA synthesis;
J. Cell Biol. 136 1201–1212
Speckman R A, Garg A, Du F, Bennett L, Veile R, Arioglu E, Taylor 
S I, Lovett M and Bowcock A M 2000 Mutational and haplotype 
analyses of families with familial partial lipodystrophy 
(Dunnigan variety) reveal recurrent missense mutations in the 
globular C-terminal domain of lamin A/C; Am. J. Hum. Genet. 
66 1192–1198
Spector D L 2003 The dynamics of chromosome organisation and 
gene regulation; Ann. Rev. Biochem. 72 573–608
Starr D A and Han M 2003 ANChors away: an actin-based 
mechanism of nuclear positioning; J. Cell Sci. 116 211–216
Stuurman N, Heins S and Aebi U 1998 Nuclear lamins : Their 
structure, assembly and interactions; J. Struc. Biol. 122 42–46
Sullivan T, Escalante-Alcade D, Bhatt H, Anver M, Bhat N, 
Nagashima K, Stewart C L and Burke B 1999 Loss of A-type 
lamin expression compromises nuclear envelope integrity 
leading to muscular dystrophy; J. Cell Biol. 147 913–920
Taniura H, Glass C and Gerace L 1995 A chromatin binding site 
in the tail domain of nuclear lamins that interacts with core 
histones; J. Cell Biol. 131 33–44
Taylor M R, Slavov D, Gajewski A, Vlcek S, Ku L, Fain P R, 
Carniel E, Di Lenarda A, Sinagra G, Boucek M M et al 2005 
Thymopoietin (lamina-associated polypeptide 2) gene mutation 
associated with dilated cardiomyopathy; Hum. Mutat. 26 
566–574
Tsai M Y, Wang S, Heidinger J, Shumaker D, Adam S A, Goldman 
R D and Zheng Y 2006 A mitotic lamin B matrix induced by 
RanGTP required for spindle assembly; Science 311 1887–1893
Van Berlo J H, Voncken J W, Broers J L, Duisters R, van Leeuwen 
R E, Crijns H J, Ramaekers F C, Hutchison C J and Pinto Y 
M 2005 A-type lamins are essential for TGF-β1 induced PP2A 
to dephosphorylate transcription factors; Hum. Mol. Genet. 14 
2839–2849 
Nuclear lamins and disease 421
J. Biosci. 31(3), September 2006
van der Kooi A J, Bonne G, Eymard B, Duboc D, Talim B, Van 
der Valk M, Reiss P, Richard P, Demay L, Merlini L et al 2002 
Lamin A/C mutations with lipodystrophy, cardiac abnormalities, 
and muscular dystrophy; Neurology 59 620–623
van Engelen B G M, Muchir A, Hutchison C J, van der Kooi 
A J, Bonne G and Lammens M 2005 The lethal phenotype 
of a homozygous nonsense mutation in the lamin A/C gene; 
Neurology 64 374–376 
Varela I, Cadinanos J, Pendas A M, Gutierrez-Fernandez 
A, Folgueras A R, Sanchez L M, Zhou Z, Rodriguez F J,
Stewart C L, Vega J A et al 2005 Accelerated ageing in mice 
defi cient in Zmpste24 protease is linked to p53 signalling 
activation; Nature (London) 437 564–568
Varga R, Eriksson M, Erdos M R, Olive M, Harten I, Kolodgie 
F, Capell B C, Cheng J, Faddah D, Perkins S et al 2006 
Progressive vascular smooth muscle cell defects in a mouse 
model of Hutchinson-Gilford progeria syndrome; Proc. Natl. 
Acad. Sci. USA 103 3250–3255 
Vergnes L, Peterfy M, Bergo M O, Young S G and Reue K 2004 
Lamin B1 is required for mouse development and nuclear 
integrity; Proc. Natl. Acad. Sci. USA 101 10428–10433 
Vigouroux C, Auclair M, Dubosclard E, Pouchelet M, Capeau 
J, Courvalin J C and Buendia B 2001 Nuclear envelope 
disorganisation in fi broblasts from lipodystrophic patients
with heterozygous R482Q/W mutations in the lamin A/C gene; 
J. Cell Sci. 114 4459–4468
Vital A, Ferrer X, Goizet C, Rouanet-Larriviere M, Eimer S, Bonne 
G and Vital C 2005 Peripheral nerve lesions associated with a 
dominant missense mutation, E33D, of the lamin A/C gene; 
Neuromuscul Disord. 15 618–621
Walter J, Sun L and Newport J 1998 Regulated chromosomal DNA 
replication in the absence of a nucleus; Mol. Cell 1 519–529
Waterham H R, Koster J, Mooyer P, Noort Gv G, Kelley R I, 
Wilcox W R, Wanders R J, Hennekam R C and Oosterwijk J C 
2003 Autosomal recessive HEM/Greenberg skeletal dysplasia is 
caused by 3-beta-hydroxysterol-delta-14-reductase defi ciency 
due to mutations in the lamin B receptor gene; Am. J. Hum. 
Genet. 72 1013–1017
Wilson K 2000 The nuclear envelope, muscular dystrophy and 
gene expression; Trends Cell Biol. 10 125–129
Worman H J and Courvalin J-C 2004 How do mutations in lamins 
A and C cause disease?; J. Clin. Invest. 113 349–351
Wydner K L, McNeil J A, Lin F, Worman H J and Lawrence J B 
1996 Chromosomal assignment of human nuclear envelope 
protein genes LMNA, LMNB1, and LBR by fl uorescence in situ 
hybridization; Genomics 32 474–478 
Yang S H, Bergo M O, Toth J I, Qiao X, Hu Y, Sandoval S, Meta 
M, Bendale P, Gelb M H, Young S G and Fong L G 2005 
Blocking protein farnesyltransferase improves nuclear blebbing 
in mouse fi broblasts with a targeted Hutchinson–Gilford 
progeria syndrome mutation; Proc. Natl. Acad. Sci. USA 102 
10291–10296
Zastrow M S, Vicek S and Wilson K L 2004 Proteins that bind A-
type lamins: integrated isolated clues; J. Cell Sci. 117 979–987
Zastrow M S, Flaherty D B, Benian G M and Wilson K L 2006 
Nuclear titin interacts with A- and B-type lamins in vitro and
in vivo; J. Cell Sci. 119 239–249
Zhang Q, Ragnauth C, Greener M J, Shanahan C M and Roberts 
R G 2002 The nesprins are giant actin-binding proteins, 
orthologous to Drosophila melanogaster muscle protein MSP-
300; Genomics 80 473–481
Zhang Q, Ragnauth C D, Skepper J N, Worth N F, Warren D T, 
Roberts R G, Weissberg P L, Ellis J A and Shanahan C M 2005 
Nesprin-2 is a multi-isomeric protein that binds lamin and 
emerin at the nuclear envelope and forms a subcellular network 
in skeletal muscle; J. Cell Sci. 118 673–687
Zhou B B and Elledge S J 2000 The DNA damage response, putting 
checkpoints in perspective; Nature (London) 408 433–439
MS received 11 May 2006; accepted 7 July 2006
ePublication: 8 August 2006
Corresponding editor: VIDYANAND NANJUNDIAH
